newsfilter
← Latest News
GlobeNewswire·

Halozyme and Skye Bioscience Announce Global Collaboration and License Agreement to Evaluate Nimacimab Co-Formulated with ENHANZE® for Obesity

SAN DIEGO, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Halozyme Therapeutics, Inc. (NASDAQ:HALO) and Skye Bioscience, Inc. (NASDAQ:SKYE) today announced the companies entered into a non-exclusive global collaboration and license